OBX OBSIDIAN THERAPEUTICS INC
FollowCommon Stock, $0.0001 par value per share (common), issuer CIK 2130606
No 13F filer reports this security in the loaded quarters.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Paradigm Biocapital Advisors LP(group Paradigm Biocapital Advisors LP)
4,101,576 shares, 6.6% in a 13G as of 2026-09-28,0001104659-26-113688
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
Events
Paradigm Biocapital Advisors LP and 3 other reporting persons reported 4,101,576 OBX shares, 6.6% of the class, as of 2026-09-28, in a 13G filed 2026-10-05. 0001104659-26-113688
Accepted , ingested